Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo

doi:10.3748/wjg.v22.i12.3341

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7657)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-4) series.

Item

Count

PDF

537

WORD

239

HTML

3623

Figures (1-7)

310

Tables (1-4)

274

Sum=4983

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

867

Download

1807

Sum=2674

Mar 28, 2016 (publication date) through Dec 2, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Mar 28, 2016; 22(12): 3341-3354
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3341

Full Size Figure Download Figure

Figure 4 High AQP3 and low AQP9 expression predict worse survival in hepatocellular carcinoma patients. A and B: Survival of 30 hepatocellular carcinoma patients, including both untreated and HCC-treated patients using Kaplan-Maier analysis. High AQP3 and low AQP9 levels resulted in lower patient survival. HCC: Hepatocellular carcinoma.

Citation: Peng R, Zhao GX, Li J, Zhang Y, Shen XZ, Wang JY, Sun JY. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo. World J Gastroenterol 2016; 22(12): 3341-3354
URL: https://www.wjgnet.com/1007-9327/full/v22/i12/3341.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i12.3341